Mukka Proteins has deferred the completion of its proposed acquisition of a majority stake in its Vietnam arm, citing delays in securing regulatory approvals in the country, the company said in a stock exchange filing on Tuesday.
The food protein maker had earlier announced plans to acquire up to 70% of the issued and paid-up share capital of Mukka Proteins Vietnam Co., Ltd. for an amount not exceeding ₹10 lakh.
While the transaction was earlier expected to be completed by June 30, 2026, the company has now revised the timeline to December 31, 2026.
“The delay is on account of regulatory approvals in Vietnam,” the company said, adding that it is taking all necessary steps to address the issues and complete the acquisition through a share transfer in due course.
